Pregnancy and systemic vasculitis

The systemic vasculitides are rare diseases of vessel wall inflammation. They are classified according to the vessel wall size. Systemic vasculitis is usually diagnosed after the fifth decade of life, except Takayasu arteritis and Bechet's disease which can manifest earlier. The increase in understanding of etiopathogenesis and effective treatment strategies have significantly improved outcomes associated with vasculitis, and more patients are living longer than ever. Primary systemic vasculitis in women of reproductive age group poses a special challenge. The diseases as well as the drugs used in their treatment affect fertility. Vasculitis increases maternal and fetal complications during pregnancy. However, there is some immunological rationale to suggest that normal hormonal and immunological changes in the maternal body may improve the tolerance to certain Th1-modulated syndromes. The successful outcome of pregnancy depends on vasculitis activity status, type of immunosuppressive medications, and maternal comorbidities. The inherent risks and ethical dilemmas of conducting clinical trials in this group of patients remain an obstacle in collecting high-quality evidence. The pregnancy should be monitored closely by a specialist team comprising a rheumatologist, an obstetrician, and other specialties as per organ involvement to ensure a successful outcome.

[1]  P. Merkel,et al.  EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis , 2016, Annals of the rheumatic diseases.

[2]  C. Gordon,et al.  BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding-Part I: standard and biologic disease modifying anti-rheumatic drugs and corticosteroids. , 2016, Rheumatology.

[3]  D. D'cruz,et al.  Pregnancy outcome in patients with systemic vasculitis: a single-centre matched case-control study. , 2015, Rheumatology.

[4]  F. Taran,et al.  Ovarian reserve alterations in premenopausal women with chronic inflammatory rheumatic diseases: impact of rheumatoid arthritis, Behçet's disease and spondyloarthritis on anti-Müllerian hormone levels. , 2015, Rheumatology.

[5]  A. Tincani,et al.  Systemic vasculitis and pregnancy: a multicenter study on maternal and neonatal outcome of 65 prospectively followed pregnancies. , 2015, Autoimmunity reviews.

[6]  A. Salama,et al.  Successful outcome of pregnancy in patients with anti-neutrophil cytoplasm antibody-associated small vessel vasculitis. , 2015, Kidney international.

[7]  R. Pereira,et al.  Reduced Ovarian Reserve in Patients with Takayasu Arteritis , 2014, The Journal of Rheumatology.

[8]  K. Wilson,et al.  Cogan Syndrome in Pregnancy , 2014, Obstetrics and gynecology.

[9]  E. Ben-Chetrit Behçet's syndrome and pregnancy: course of the disease and pregnancy outcome. , 2014, Clinical and experimental rheumatology.

[10]  S. Dogra,et al.  Uncommon presentations of primary systemic necrotizing vasculitides: the Great Masquerades , 2013, International journal of rheumatic diseases.

[11]  A. Ornoy,et al.  Pregnancy outcome following gestational exposure to TNF-alpha-inhibitors: a prospective, comparative, observational study. , 2014, Reproductive toxicology.

[12]  D. D'cruz,et al.  B-cell depletion therapy and pregnancy outcome in severe, refractory systemic autoimmune diseases. , 2013, Journal of autoimmunity.

[13]  N. Costedoat-Chalumeau,et al.  Behçet's disease and pregnancy. , 2013, Arthritis and rheumatism.

[14]  P. Merkel,et al.  2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. , 2013, Arthritis and rheumatism.

[15]  W. Yoong,et al.  Diagnosis and management of henoch-schönlein purpura in pregnancy: a review of the literature , 2012, Archives of Gynecology and Obstetrics.

[16]  M. Sargin,et al.  Pregnancy in a patient with Wegener's granulomatosis: a case report. , 2012, Bulletin of the NYU hospital for joint diseases.

[17]  P. Ghosh,et al.  Takayasu arteritis in pregnancy: an analysis from eastern India , 2012, Archives of Gynecology and Obstetrics.

[18]  S. Chow,et al.  Ovarian reserve diminished by oral cyclophosphamide therapy for granulomatosis with polyangiitis (Wegener's) , 2011, Arthritis care & research.

[19]  Li'na Hu,et al.  Adjuvant gonadotropin-releasing hormone analogues for the prevention of chemotherapy induced premature ovarian failure in premenopausal women. , 2011, The Cochrane database of systematic reviews.

[20]  L. Mouthon,et al.  Pregnancies in systemic necrotizing vasculitides: report on 12 women and their 20 pregnancies. , 2011, Rheumatology.

[21]  R. Wagner-Bastmeyer,et al.  Stable incidence of primary systemic vasculitides over five years: results from the German vasculitis register. , 2005, Arthritis and rheumatism.

[22]  G. Hebisch,et al.  Pregnancy in patients with rheumatic disease: anti-inflammatory cytokines increase in pregnancy and decrease post partum , 2004, Annals of the rheumatic diseases.

[23]  Y. Sidi,et al.  Systemic Vasculitis Presenting as a Tumorlike Lesion: Four Case Reports and an Analysis of 79 Reported Cases , 2000, Medicine.

[24]  S. Jain,et al.  Outcome of pregnancy in Takayasu arteritis. , 2000, International journal of cardiology.

[25]  D. Adu,et al.  Intravenous immunoglobulin for ANCA-associated systemic vasculitis with persistent disease activity. , 2000, QJM : monthly journal of the Association of Physicians.

[26]  I. Crocker,et al.  Neutrophil function in pregnancy and rheumatoid arthritis , 2000, Annals of the rheumatic diseases.

[27]  M. Liang,et al.  Preserving ovarian function in patients receiving cyclophosphamide , 1999, Lupus.

[28]  T. Katoh,et al.  Successful pregnancy after coronary artery bypass grafting for Kawasaki disease , 1998, Acta paediatrica Japonica : Overseas edition.

[29]  F. Breedveld,et al.  Influence of HLA-class II incompatibility between mother and fetus on the development and course of rheumatoid arthritis of the mother , 1998, Annals of the rheumatic diseases.

[30]  C. T. Boylen,et al.  Successful treatment of Wegener's granulomatosis during pregnancy: a case report and review of the medical literature. , 1998, Chest.

[31]  A. J. Leu,et al.  [Takayasu arteritis and pregnancy]. , 1996, Deutsche medizinische Wochenschrift.

[32]  T. Mosmann,et al.  Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon? , 1993, Immunology today.

[33]  J. Owen,et al.  Polyarteritis nodosa in pregnancy: A case report and brief literature review , 1989, American journal of obstetrics and gynecology.